Ter Heine R, van den Bosch BJC, van Geel RM, van Geffen WH, et al. Optimizing lazertinib therapy through GSTM1 genotyping: a strategy to reduce excess drug exposure and potential toxicity. Cancer Chemother Pharmacol 2025;95:105.
PMID: 41198911